- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Cipla Limited — Updates, 23-01-2026: Press Release
23-01-2026 | 01:41 pm
23-01-2026 | 01:41 pm
Cipla's Q3 results show global revenue flat at INR 7,074 Cr due to gRevlimid impact, leading to PAT of INR 676 Cr (-57% YoY). India business grew 10%. North America revenue was $167 Mn, with future launches expected to cushion declines. R&D investments rose 37% to INR 494 Cr.
No comments yet. Be the first to comment!